Dilution of Share Value from the Exercise of Stock Acquisition Rights
First written in FY2021. 5 of 8 entries say "Materialised", first in FY2022-Q3. Latest entry: FY2025.
Science Arts moved to the "Worse" side of this theme in 2022, 2 years after the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
53 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「As of the end of the fiscal year, the potential shares underlying share acquisition rights amounted to 240,000 shares, equivalent to 2.8% of the total of 8,459,500 issued shares and potential shares.」
The potential share ratio decreased from 3.6% in the previous fiscal year to 2.8%. During the fiscal year, the company also disposed of 10,000 treasury shares through the exercise of share acquisition rights. - FY2024MitigatedAnnual report
「As of the end of the fiscal year, the potential shares underlying share acquisition rights amounted to 252,000 shares, equivalent to 3.6% of the total of 6,968,400 issued shares and potential shares.」
Potential shares decreased from 260,000 shares, or 3.7%, to 252,000 shares, or 3.6%. Potential dilution from the exercise of share acquisition rights continued to be disclosed. - FY2023MaterialisedAnnual report
「As of the end of the fiscal year, the potential shares underlying share acquisition rights amounted to 260,000 shares, equivalent to 3.7% of the total of 6,976,400 issued shares and potential shares.」
The company disclosed 260,000 potential shares underlying share acquisition rights, representing potential dilution of 3.7%. During the fiscal year, it also disposed of 18,000 shares through the exercise of share acquisition rights and received ¥14.9 million. - FY2023-Q2MaterialisedAnnual report
「Cash provided by financing activities during the six-month period ended 30 September was ¥14.9 million, compared with ¥310.287 million in the same period of the previous year. This was attributable to ¥14.9 million in proceeds from the disposal of treasury shares through the exercise of share acquisition rights.」
The disposal of treasury shares through the exercise of share acquisition rights also occurred during the six-month period ended 30 September, generating ¥14.9 million in proceeds. - FY2023-Q1MaterialisedAnnual report
「The above figures are based on the shareholder register as of the immediately preceding record date, 31 August 2022. However, during the three-month accounting period ended 30 September, the exercise of share acquisition rights (stock options) reduced treasury shares by 7,000, to 68,400 shares, as of the end of the three-month accounting period.」
The exercise of share acquisition rights also occurred during the first quarter, reducing treasury shares by 7,000. - FY2022MaterialisedAnnual report
「"Status of disposal and holdings of acquired treasury shares" / "Other (exercise of share acquisition rights)": 37,000 shares; total disposal value: ¥13.5 million」
The disposal of 37,000 treasury shares through the exercise of share acquisition rights was reported, indicating that dilution risk continued to materialise. Potential shares at the end of the period were 152,000, equivalent to 4.3% of issued shares and other shares. - FY2022-Q3MaterialisedAnnual report
「(Note) The above figures are based on the shareholder register as of the immediately preceding record date, 28 February 2022. However, during the three-month accounting period ended 31 December, the exercise of share acquisition rights (stock options) reduced fully voting shares (treasury shares and other) by 36,000 shares, to 76,400 shares, as of the end of the three-month accounting period.」
The exercise of share acquisition rights (stock options) actually occurred, and the company reported a 36,000-share reduction in treasury shares. - FY2021First statedAnnual report
「As of the filing date, the potential shares underlying share acquisition rights amounted to 241,600 shares, equivalent to 6.7% of the total of 3,597,600 issued shares and potential shares.」
The company disclosed potential dilution of 6.7% upon the exercise of stock options.